PanTera

Belgium · Biotechnology, Health Care, Manufacturing · 1,000 employees

PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general.

See plans & pricing → Track PanTera’s funding, hiring, and signals — with verified contacts — on Fundz.